Document is current
Any future updates will be listed below
-
Authors
Ren, Zhijian
Zhang, Minqiao
Wang, Pingping
Chen, Kanan
Wang, Jing
Wu, Lingping
Hong, Yue
Qu, Yihui
Luo, Qun
Cai, Kedan
-
Funding
Funding for this research was provided by:
the Ningbo City Public Welfare Research Program (2024S162)
the Ningbo Major Research and Development Plan Project (2024Z213)
the Zhejiang Provincial Medical and Health Project (2024KY336)
the Provincial and Municipal Joint Medical Key Discipline (2022-S03)
the Ningbo Health Science and Technology Plan Project (2023Y89)
- License Information
-
More Information
Article History
Received: 29 August 2024
Accepted: 10 January 2025
First Online: 17 February 2025
Declarations
:
: In China, all experimental protocols were approved by the Ethics Committee of Ningbo Second Hospital (Ethics Approval Number: KY202301501) and the Ethics Committee of Xiangshan County First People’s Hospital (Ethics Approval Number: XYYJ-2024-660). This study utilized de-identified data from patients undergoing hemodialysis at Ningbo Second Hospital and Xiangshan County First People’s Hospital between August 1, 2019, and September 30, 2023. The data no longer contained personally identifiable information, and the analysis posed minimal risk to participants. In accordance with Article 5(1) of Sect. 5, Chap. 2, from the 2023 Guidelines for the Establishment of Ethics Committees for Clinical Research Involving Humans, as well as the Declaration of Helsinki, the Ethics Committees granted a waiver of informed consent due to the retrospective nature of the study.
: The authors declare no competing interests.
: Not applicable.
